Technology Transfer Office
Actualité - Partnership

P-LICAN: Promoting oncology innovation in Paris Region

Institut Curie
Paris Region Cancer Research cluster (Cancéropôle Île-de-France) and Competitiveness Health Cluster (Medicen Paris Region) announce the launch of P-LICAN (Paris region Leading Innovation for CANcer), a joint program to strengthen the economic value of oncology research from Paris region through public-private national and international partnerships.
logo P-LICAN

Leading national player in the care of cancer patients, Paris Region is also the first region for research on this disease. Research work, clinical trials, scientific publications, hospital care ... the mobilization in Paris region is a real source of strength for both research and care.

In this environment, the Cancer Resarch Cluster (Cancéropôle Ile-de-France) has structured a strong network that promotes the pooling of skills and resources between actors in academic research. On the industrial front, Medicen Paris Region, the competitiveness cluster dedicated to healthcare, offers a unique place where SMEs, startups, major industrial players, academic research and healthcare professionals work together to bring innovative solutions to the market for patients. In addition, Paris region hosts half of French biotech companies. It is the first region in Europe by the number of companies in the pharmaceutical sector and the second by the number of companies in the "medical equipment" sector.

From this observation is born the will to develop a joint action to accelerate the economic valuation of the oncology research coming from Paris Region, built around Médicen Paris Region and the founding members of the Cancéropôle IDF which are the Assistance Publique-Hôpitaux de Paris, Institut Curie, Institut Pasteur, Gustave Roussy and associated universities, mobilizing their technology transfer office

The objectives of the P-LICAN program

Hub to transform research and innovation in oncology into economic value at the international level, P-LICAN's mission is to promote research in oncology and improve regional networking to increase its attractiveness. P-LICAN has three main objectives:

  • To bring out innovative inter-institutional projects in oncology, at the crossroads of research and development.
  • Coordinate at regional level the technology transfer offices of the partners, and establishments of Cancéropôle Ile-de-France
  • Create an offer of innovative projects that meet medico-economic expectations for public-private partnerships.


P-LICAN embodies a new impetus given by Cancéropôle IDF in the continuation of the work begun over more than 15 years of detection, emergence and structuring of oncology projects at the regional level. The action implemented with the active support of the technology transfer offices of the founding establishments of Cancéropôle IDF and MEDICEN Paris Région must result in structuring a regional offer for ambitious inter-institutional public-private partnerships, says Pr. Hervé FRIDMAN, President of Cancéropôle Ile-de-France

MEDICEN Paris Région is delighted with the agreement with Cancéropôle IDF for this program. P-LICAN will contribute to bring new projects eligible for labeling by MEDICEN Paris Region and strengthen the cluster's links with the academic and clinical fabric. Oncology is an extremely dynamic sector that fits into several areas of MEDICEN's strategic activities. The stakes are up to the ambition of the P-LICAN program: to make Île-de-France, a visible, readable and attractive territory in oncology at the international level, and thus meet a repeated demand from industry and industry. investors "adds Christian LAJOUX, President of MEDICEN Paris Region.


"P-LICAN is a unique opportunity for the coordination of cancer research and care forces in Île-de-France. When it is relevant, we will be able to coordinate the actions of Cancéropôle IDF establishments around projects of a critical size on a worldwide scale, a condition necessary to be offensive on the international stage. The Paris region's academic, clinical and economic oncology ecosystem is at the forefront, but its structure and international visibility need to be improved. completes Amaury MARTIN, Institut Curie, and coordinator of P-LICAN for the Cancéropôle Ile-de-France.